Emerging Technologies for Rapid Phenotypic AST of Clinical Isolates of Bacteria (JCM ed.)
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Emerging Technologies for Rapid Phenotypic AST of Clinical Isolates of Bacteria (JCM ed.)
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Antimicrobial resistance is one of the largest threats to global public health, compromising all other advances in modern medicine. At the forefront of detecting AMR is the clinical laboratory.
However, walk into any clinical microbiology laboratory today and you will find this important task being accomplished using techniques that barely evolved from the methods proposed by Alexander Fleming, nearly 100 years ago.
Bacteria are exposed to antimicrobials, in an in vitro culture system, and growth inhibition is measured after overnight incubation. In the time of laboratory automation, molecular testing and artificial intelligence – are we ready for an antimicrobial susceptibility testing revolution? What are the technologies that might get us there?
Guests:
- Dr. Daniel Rhodes
- Dr. Jacob Rattin
This episode of Editors in Conversation is brought to you by the Journal of Clinical Microbiology and hosted by JCM Editor in Chief, Romney Humphries, Ph.D., D(ABMM) and Elitza (Elli) Theel, Ph.D., D(ABMM). JCM is available at jcm.asm.org.
Visit journals.asm.org/journal/jcm to read articles and/or submit a manuscript.
Become an ASM member to receive up to 50% off publishing fees when you publish in JCM or any of the ASM journals. Sign up at asm.org/joinasm.